Starvog M 0.3 Tablet SR
Prescription Required
10 Tablet
Manufacturer
Merck LtdStorage
Store below 30°C
- Starvog M 0.3 Tablet SR prevents Type 2 diabetes.
- Starvog M 0.3 Tablet SR helps to prevent the future risk of limb loss, blindness, nerve issues, and kidney damage.
- Details
- Benefits
- Side effects
Starvog M 0.3 Tablet SR is an anti-diabetic medication. Starvog M 0.3 Tablet SR is used to treat type 2 diabetes mellitus. A metabolic condition known as diabetes mellitus is typified by high blood sugar levels. It happens when insulin (a hormone produced by the pancreatic beta cells) is resistant to breaking down glucose to create energy (insulin resistance) or when the pancreas (an organ beneath the stomach) produces little or no insulin at all.
Usage instructions-
- Starvog M 0.3 Tablet SR is used as directed by your doctor. With food or without, you can take the Starvog M 0.3 Tablet SR.
How it works-
Metformin and Voglibose are included in Starvog M 0.3 Tablet SR. Metformin reduces sugar synthesis and absorption in your body, allowing you to make better use of your current insulin. Voglibose inhibits the intestinal enzymes that break down complex carbohydrates into simple sugars like glucose. This keeps blood glucose levels from rising very high after meals.
Safety information-
Pregnancy
Starvog M 0.3 Tablet SR is probably not safe to use during pregnancy. There are limited human studies, but animal studies have shown adverse effects on the developing baby. Consult your doctor.
Breastfeeding
It is probably not safe to breastfeed while taking Starvog M 0.3 Tablet SR. Limited human data suggests that the drug may enter breast milk and cause harm to the baby.
Alcohol
Avoid alcohol consumption with Starvog M 0.3 Tablet SR. It is not safe.
Driving
Starvog M 0.3 Tablet SR does not affect your drive.
Kidney
Starvog M 0.3 Tablet SR should be administered with caution to patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.
Liver
Limited information is available on the usage of Starvog M 0.3 Tablet SR in liver disease patients. Please consult your doctor.
Starvog M 0.3 Tablet SR is a medication used to treat type 2 diabetes. Starvog M 0.3 Tablet SR includes Voglibose and Metformin. Voglibose belongs to the alpha-glucosidase inhibitor class. It slows glucose absorption by blocking intestinal enzymes that convert complex carbohydrates into simple sugars like glucose. This procedure keeps blood glucose levels from rising quickly after meals. The biguanide medication class includes Metformin. It demonstrates a non-pancreatic impact in lowering blood glucose levels while enhancing insulin secretion. Because it amplifies the effects of insulin, it is also known as an insulin sensitizer. It is regarded as a novel anti-diabetic medication since it does not reduce blood sugar levels. Metformin, in most circumstances, does not induce weight gain.
- Vomiting
- Abdominal pain
- Flatulence
- Nausea
- Taste change
- Headache



